[1]王春晓*,任娜,闫锡钊,等.血清Sestrin 2在子痫前期中的表达及其与不良妊娠结局的关系[J].中国计划生育和妇产科,2019,(12):90-94.
　WANG Chun-xiao*,REN Na,YAN Xi-zhao,et al.Expression of serum Sestrin 2 in preeclampsia and its relationship with adverse pregnancy outcomes[J].Chinese Journal of Family Planning & Gynecotokology,2019,(12):90-94.
点击复制

血清Sestrin 2在子痫前期中的表达及其与不良妊娠结局的关系
分享到：

《中国计划生育和妇产科》[ISSN:1674-4020/CN:51-1708/R]

卷:
期数:
2019年12期
页码:
90-94
栏目:
论著与临床
出版日期:
2019-12-25

文章信息/Info

Title:
Expression of serum Sestrin 2 in preeclampsia and its relationship with adverse pregnancy outcomes
作者:
王春晓1*; 任娜1; 闫锡钊1 ; 董家丽2; 苗艳3
沧州市人民医院，1.妇科；2. 检验科；3.产科
Author(s):
WANG Chun-xiao1*; REN Na1; YAN Xi-zhao1 ; DONG Jia-li2; MIAO Yan3
1. Department of Gynecology; 2. Laboratory; 3. Department of Obstetrics，Cangzhou People's Hospital, Cangzhou Hebei 061000, P.R.China
关键词:
子痫前期; Sestrin 2; 妊娠结局; 危险因素; 预测价值
Keywords:
preeclampsia;  Sestrin 2;  pregnancy outcome;  risk factors;  predictive value
分类号:
R 71424
摘要:
目的探讨血清Sestrin 2在子痫前期（preeclampsia，PE）中的表达及其与不良妊娠结局的关系。方法选取2017年1月至2018月6月在沧州市人民医院接受治疗的PE患者90例，根据疾病严重程度将其分为重度PE组（38例）和轻度PE组（52例），另选取在我院行孕检的健康孕妇40例作为健康对照组。采用酶联免疫吸附试验检测血清中Sestrin 2的水平。比较3组研究对象血清中Sestrin 2的水平，分析PE患者不良妊娠结局的危险因素，采用受试者操作特征曲线分析血清Sestrin 2对PE患者不良妊
Abstract:
ObjectiveTo investigate the expression of serum Sestrin 2 in preeclampsia (PE) and its relationship with adverse pregnancy outcomes. Methods90 patients with PE treated in Cangzhou People's Hospital from January 2017 to June 2018 were selected and divided

参考文献/References:

［1］Henderson J T,Thompson J H,Burda B U,et al.Preeclampsia Screening ［J］. JAMA,2017,317(16):1668-1683. ［2］Phipps E,Prasanna D,Brima W,et al.Preeclampsia:Updates in pathogenesis, definitions, and guidelines ［J］.Clin J Am Soc Nephrol,2016,11(6):1102-1113. ［3］王润梅,杨秋红,张芳,等.子痫前期患者远期预后及其后代发病风险的评估［J］.山东大学学报（医学版）,2017,55(12):31-35. ［4］Wu F,Tian FJ,Lin Y,et al. Oxidative stress: placenta function and dysfunction ［J］.Am J Reprod Immunol,2016,76(4):258-271. ［5］彭聪.孕妇血清、脐血及胎盘组织中髓过氧化物酶水平和子痫前期发病的关系 ［J］.临床和实验医学杂志,2016,15(3):270-272. ［6］张晗,刘方琮,蔡丽瑛.子痫前期胎盘组织中氧化应激、热休克蛋白27和热休克转录因子1的表达及意义 ［J］.中国计划生育和妇产科,2017,9(8):21-22,38. ［7］李林,韩薇.应激诱导蛋白Sestrin的研究进展 ［J］.中国循证心血管医学杂志,2017,9(7):890-891,894. ［8］郭明,夏中元.Sestrin2抗氧化应激作用在缺血再灌注中的研究进展 ［J］.中国医药导报,2017,14(17):28-31. ［9］谢幸,苟文丽.妇产科学 ［M］.第8版.北京:人民卫生出版社,2013:64-73. ［10］D'Souza V,Rani A,Patil V,et al. Increased oxidative stress from early pregnancy in women who develop preeclampsia ［J］.Clin Exp Hypertens,2016,38(2):225-232. ［11］徐欣然,陈叙,崔洪艳,等.滋养细胞凋亡的二阶段与子痫前期二阶段发病机制关系的探讨 ［J］.国际妇产科学杂志,2017,44(5):535-538. ［12］伍天文,王钢,李晓青,等.子痫前期发病机制的研究现状 ［J］.基因组学与应用生物学,2017,36(3):1266-1271. ［13］徐霞,张延珍,王慧兰,等.子痫前期并发脏器受累的孕妇血清及胎盘氧化应激损伤水平研究 ［J］.国际妇产科学杂志,2016,43(1):39-42. ［14］钱中清,李新萍,王才智,等.重度子痫前期患者血清对人脐静脉血管内皮细胞的氧化性损伤研究 ［J］.中华妇产科杂志,2013,48(3):193-197. ［15］Cardoso P M,Surve S.The Effect of Vitamin E and Vitamin C on the prevention of preeclampsia and newborn outcome: A case–control study ［J］.J Obstet Gynaecol India,2016,66(Suppl1):271-278. ［16］Saveljeva S,Cleary P,Mnich K,et al.Endoplasmic reticulum stress-mediated induction of SESTRIN 2 potentiates cell survival ［J］. Oncotarget, 2016,7(11): 12254-12266. ［17］Tayyar AT,Tayyar A,Kozali S,et al.Maternal serum sestrin 2 levels in preeclampsia and their relationship with the severity of the disease ［J］.Hypertens Pregnancy,2019,38(1):13-19. ［18］刘锋,胡红娟,范文静.干扰Sestrin2表达对ox-LDL诱导的人脐静脉内皮细胞凋亡的影响 ［J］.中国动脉硬化杂志,2016,24(4):350-354. ［19］Pasha M,Eid AH,Eid AA,et al.Sestrin2 as a novel biomarker and therapeutic target for various diseases ［J］.Oxid Med Cell Longev,2017,2017:3296294. ［20］王丽雪,祝筱梅,卢中秋,等.应激诱导蛋白Sestrin2研究进展 ［J］.生理科学进展,2018,49(2):139-143. ［21］Kovo M,Schreiber L,Elyashiv O,et al.Pregnancy outcome and placental findings in pregnancies complicated by fetal growth restriction with and without preeclampsia ［J］.Reprod Sci,2015,22(3):316-321. ［22］邹郁松,路军丽,丁小英,等.2012～2014年7794例高危及危重孕产妇救治管理与分析［J］.中国医药导报,2015,12(28):59-62.

相似文献/References:

[1]宋改让,傅晓冬,刘华梅,等.IL-6、CRP在子痫前期中的意义[J].中国计划生育和妇产科,2009,(05):0.
　SONG Gai-rang,FU Xiao-dong,LIU Hua-meiThe department of gynaecology and obstetrics,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2009,(12):0.
[2]李延杰.早发型重度子痫前期妊娠116例结局分析[J].中国计划生育和妇产科,2010,(02):0.
　LI Yan-jie.[J].Chinese Journal of Family Planning & Gynecotokology,2010,(12):0.
[3]赵昆.D-二聚体测定在产科常见病理性高凝状态疾病的临床意义[J].中国计划生育和妇产科,2011,(04):0.
　ZHAO Kun.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(12):0.
[4]张峰,丁金云.子痫前期患者血清瘦素、sFlt-1/PLGF、C-反应蛋白及IP-10关系的研究[J].中国计划生育和妇产科,2012,(06):0.
　ZHANG Feng,DING Jin-yun.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(12):0.
[5]乔宠,杨小梅,林其德,等.子痫前期的流行病学研究进展[J].中国计划生育和妇产科,2013,(06):0.
　QIAO Chong,YANG Xiao-mei,LIN Qi-de,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(12):0.
[6]龚云辉,周容.子痫前期的预测和预警[J].中国计划生育和妇产科,2013,(06):0.
　GONG Yun-hui,ZHOU Rong,[J].Chinese Journal of Family Planning & Gynecotokology,2013,(12):0.
[7]顾宁,胡娅莉.子痫前期的预测和预防引发的思考[J].中国计划生育和妇产科,2013,(06):0.
　GU Ning,HU Ya-li,[J].Chinese Journal of Family Planning & Gynecotokology,2013,(12):0.
[8]郭宏霞,杨孜.子痫前期发病时期对母儿影响[J].中国计划生育和妇产科,2013,(06):0.
　GUO Hong-xia,YANG Zi,[J].Chinese Journal of Family Planning & Gynecotokology,2013,(12):0.
[9]宋亦军,刘俊涛.炎症与子痫前期[J].中国计划生育和妇产科,2013,(06):0.
　SONG Yi-jun,LIU Jun-tao,[J].Chinese Journal of Family Planning & Gynecotokology,2013,(12):0.
[10]乐怡平,林建华.子痫前期转运与分娩处理[J].中国计划生育和妇产科,2013,(06):0.
　LE Yi-ping,LIN Jian-hua,[J].Chinese Journal of Family Planning & Gynecotokology,2013,(12):0.

备注/Memo

备注/Memo:
2018年沧州市科学计划自筹经费项目（项目编号：183302062）
更新日期/Last Update: 2019-12-25